Download resynchronisation therapy in adults with congenital heart disease

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Remote ischemic conditioning wikipedia , lookup

History of invasive and interventional cardiology wikipedia , lookup

Management of acute coronary syndrome wikipedia , lookup

Artificial heart valve wikipedia , lookup

Coronary artery disease wikipedia , lookup

Heart failure wikipedia , lookup

Aortic stenosis wikipedia , lookup

Hypertrophic cardiomyopathy wikipedia , lookup

Myocardial infarction wikipedia , lookup

Quantium Medical Cardiac Output wikipedia , lookup

Cardiac contractility modulation wikipedia , lookup

Lutembacher's syndrome wikipedia , lookup

Electrocardiography wikipedia , lookup

Cardiac surgery wikipedia , lookup

Mitral insufficiency wikipedia , lookup

Congenital heart defect wikipedia , lookup

Dextro-Transposition of the great arteries wikipedia , lookup

Heart arrhythmia wikipedia , lookup

Arrhythmogenic right ventricular dysplasia wikipedia , lookup

Transcript
1346, oral, cat:49
RESYNCHRONISATION THERAPY IN ADULTS WITH CONGENITAL
HEART DISEASE
B Skaria , T Bharucha, J Boullin, JM Morgan, AP Salmon, B Keeton, G Veldtman
Adult Congenital Cardiac Unit, Southampton University Hospital, Southampton,
Hampshire, UK
Objectives:Cardiac resynchronization therapy (CRT) may be of particular benefit to
adults with congenital heart disease (CHD) and ventricular dysfunction (VD). Methods :
Retrospective hospital records review.Results:Between 2001 & 2004, 6 patients (pt) had
5 successful implants, 4 with defibrillators (5 males, mean age 37.2 +/- 15 years).
Diagnosis included repaired Fallot (n=2),congenitally corrected transposition of great
arteries (CCTGA)(n=1),Ebstein's anomaly (n=1)and Mustard with transposition
(n=2).The 2 Mustard pt had severe arrhythmia in addition to the severe heart failure
which was common for all 6 pt.The left ventricle was paced first in the repaired Fallot pt
and the right ventricle in the others.Implantation failed in the patient with Ebstein's
anomaly.Leads were placed epicardially in the 2 Mustard pt (no transvenous access to
appropriate pacing site). High pacing thresholds due to scarring prevented early CRT in 1
pt. CRT was possible at 6 weeks. The transvenous approach was technically difficult in 3
pt: gigantic right atrium in 2 (Ebstein’s pt & CCTGA pt) & anatomic variation of
coronary sinus in 1 (CCTGA) pt. Aortic valve Doppler time velocity integral and
diastolic times were used to optimise CRT (early and at 6 weeks). At 10 months median
follow up (range 4-36), all pt improved in regional &/or global ventricular function (n=5)
and arrhythmia control (n=2:atrial fibrillation cessation in Fallot pt; ventricular
tachycardia in Mustard pt). The other Mustard pt had more frequent atrial flutter,
coinciding with changed antiarrhythmics. At last follow-up, 2 of 3 pts (Fallot pt,
CCTGA) had developed severe pulmonary ventricle atrioventricular(AV) valve
regurgitation, and recurrent heart failure (both pt had defibrillators, and the CCTGA pt
had a preexisting transvenous lead). Three of the 5 pt currently remain off the
transplantation list. Conclusion:CRT may improve hemodynamics in adults with CHD
and VD.Congenital and acquired anatomic variation dictates site and ease of lead
placement.Epicardial leads may have high pacing thresholds early after procedure. Late
AV valve regurgitation may precipitate heart failure/arrhythmia, and calls for improved
lead placement techniques especially when CRT is combined with defibrillator therapy.